Home/Filings/4/0000899243-17-016603
4//SEC Filing

Dicerna Pharmaceuticals Inc 4

Accession 0000899243-17-016603

CIK 0001399529operating

Filed

Jun 15, 8:00 PM ET

Accepted

Jun 16, 6:02 PM ET

Size

5.5 KB

Accession

0000899243-17-016603

Insider Transaction Report

Form 4
Period: 2017-06-15
ROSSKAMP RALF
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2017-06-15+250,000250,000 total
    Exercise: $2.91Exp: 2027-06-15Common Stock (250,000 underlying)
Footnotes (1)
  • [F1]The option vests 25% on the first year anniversary of the vesting start date of June 15, 2017 and the remaining 75% vests in 36 substantially equal monthly installments thereafter, subject in each case to the reporting person's continued employment with the issuer through the applicable vesting date.

Issuer

Dicerna Pharmaceuticals Inc

CIK 0001399529

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001399529

Filing Metadata

Form type
4
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 6:02 PM ET
Size
5.5 KB